Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.28 USD
Change Today +0.12 / 5.56%
Volume 489.8K
As of 8:10 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jack Goldstein Ph.D.

Chairman, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee, OncoGenex Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 2 different organizations across 8 different industries.

See Board Relationships


Dr. Jack Goldstein, Ph.D. is an Independent Consultant. Dr. Goldstein served as a General Partner of Windamere Venture Partners II, L.P. He served as President and Chief Operating Officer of Chiron Corp. from February 23, 2005 to April 2006. He served as an Interim Chief Operating Officer and Interim President of Chiron Corp., from November 4, 2004 to February 23, 2005. He also served as Vice President of Chiron Corp. since September 2002. He served as the President ...

Read Full Background

Corporate Headquarters*

19820 North Creek Parkway
Bothell, Washington 98021

United States

Phone: 425-686-1500
Fax: --

Board Members Memberships*

Former Director
Former Director
Former Director, Member of Audit Committee and Member of Corporate Governance & Nominating Committee
Former Director, Chairman of Compensation Committee and Member of Audit Committee
Independent Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Chairman, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee


St. John's University
St. John's University
St. John's University
Rider University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options17,961
Unexercisable Options5,000
Total Number of Options22,961

Total Compensation*

Total Annual Cash Compensation$87,500
Total Calculated Compensation$117,663
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OGXI:US $2.28 USD +0.12


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOGENEX PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at